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Abstract: Pregnancy is one of the more important periods in life when increased 
micronutrients, and macronutrients are most needed by the body; both for the health and 
well-being of the mother and for the growing foetus and newborn child. This brief review 
aims to identify the micronutrients (vitamins and minerals) likely to be deficient in women 
of reproductive age in Low- and Middle-Income Countries (LMIC), especially during 
pregnancy, and the impact of such deficiencies. A global prevalence of some two billion 
people at risk of micronutrient deficiencies, and multiple micronutrient deficiencies of many 
pregnant women in LMIC underline the urgency to establishing the optimal 
recommendations, including for delivery. It has long been recognized that adequate iron is 
important for best reproductive outcomes, including gestational cognitive development. 
Similarly, iodine and calcium have been recognized for their roles in development of the 
foetus/neonate. Less clear effects of deficiencies of zinc, copper, magnesium and selenium 
have been reported. Folate sufficiency periconceptionally is recognized both by the practice of 
providing folic acid in antenatal iron/folic acid supplementation and by increasing numbers 
of countries fortifying flours with folic acid. Other vitamins likely to be important include 
vitamins B12, D and A with the water-soluble vitamins generally less likely to be a problem. 
Epigenetic influences and the likely influence of micronutrient deficiencies on foetal origins 
of adult chronic diseases are currently being clarified. Micronutrients may have other more 
subtle, unrecognized effects. The necessity for improved diets and health and sanitation are 
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consistently recommended, although these are not always available to many of the world’s 
pregnant women. Consequently, supplementation programmes, fortification of staples and 
condiments, and nutrition and health support need to be scaled-up, supported by social and 
cultural measures. Because of the life-long influences on reproductive outcomes, including 
inter-generational ones, both clinical and public health measures need to ensure adequate 
micronutrient intakes during pregnancy, but also during adolescence, the first few years of 
life, and during lactation. Many antenatal programmes are not currently achieving this. We 
aim to address the need for micronutrients during pregnancy, the importance of 
micronutrient deficiencies during gestation and before, and propose the scaling-up of  
clinical and public health approaches that achieve healthier pregnancies and improved 
pregnancy outcomes. 
Keywords: adolescents; pregnant women; pregnancy; micronutrients; antenatal care;  
low- and middle-income countries (LMIC) 
 
1. Introduction 
Optimal outcomes of pregnancy and their importance to the mother, the future child, families  
and societies, is contingent on appropriate care, adequate antenatal preparation and sufficient nutrition. 
The consequences of antenatal nutritional deficiencies can be devastating to the mother, child and effect 
future generations. As such, it is critical that expectant mothers enter pregnancy with the best possible 
macronutrient and micronutrient status and then receive adequate antenatal nutrition for their health, and 
for the well-being of their offspring. This short review examines micronutrient deficiencies in women 
in Low and Middle Income Countries, and programmatic responses. 
Maternal nutrition has profound effects on foetal growth, development, and subsequent infant 
birthweight, and the health and well-being of the woman herself [1]. Maternal undernutrition, maternal 
mortality rates, infant mortality and morbidity rates have declined since the 1990s as a result of 
increasing attention to improving the quality of the antenatal period and improving obstetric care and 
social change. However, there is still a great need for further improvements. The nutritional status and 
size of the pregnant woman is the result of past health and nutrition, including her own birth size and 
subsequent health and societal influences. 
Poor dietary patterns, and options, in the periconceptional period are known to lead to pre-term 
delivery, shorter birth-length and earlier gestation [1] and poor potential neurodevelopmental outcomes 
for the foetus [2]. Given the impact of poor maternal diet, both public health and clinical measures need 
to be in place, especially in low socio-economic environments. These need to address all stages of the 
women’s life-cycle, and especially during the pregnancy. There is increased risk if that pregnancy occurs 
during adolescence, is spaced too closely to a preceding pregnancy, or is one of multiple pregnancies. 
Nutritional, dietary and health interventions need to be complemented by improved obstetric care and 
support, and exposure to “nutrition-sensitive” interventions such as access to education, improvement in 
women’s status and improved agricultural and environmental determinants [3]. 
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While the global burden of diseases caused by deficiencies of micronutrients during pregnancy is 
relatively modest globally, the cumulative individual impact can be considerable. This is especially so 
for adolescent pregnancies and women of lower economic or minority status in low and middle-income 
economic settings [4]. The aim of this short review is to describe micronutrient deficiencies and 
programmes in LMIC where the vast majority of micronutrient deficiencies occur, and appropriate 
public health and maternal antenatal care in such settings to address such deficiencies. Where relevant, 
research literature from more affluent countries is also used. 
2. Micronutrient Deficiencies in Women of Reproductive Age 
Globally, approximately two billion people, the majority women and young children, are affected, by 
micronutrient deficiencies, with even higher rates during pregnancy [5]. Concurrent deficiencies of more 
than one or two micronutrients are well documented among young pregnant women, (and young 
children), especially in LMIC [6–9]. Deficiencies in maternal micronutrient status are a result of: poor 
quality diets; high fertility rates; repeated pregnancies; short inter-pregnancy intervals; and, increased 
physiological needs. These factors are aggravated by often inadequate health systems with poor capacity, 
by poverty and inequities, and by socio-cultural factors such as early marriage and adolescent 
pregnancies, and some traditional dietary practices [3,4,10–12]. A systematic review identifying all 
studies that had been published between 1988 and 2008 reporting on micronutrient intakes in women 
living in such environments, showed that for women, the reported mean/median intakes in over 50%  
of the studies were below the Estimated Average Requirements (EAR) for micronutrient intakes,  
except for vitamin A, vitamin C, and niacin, where the reported intakes were around a third of the EAR, 
29%, 34% and 34% respectively [11]. 
Pregnancy during adolescence is a relatively common event in much of the world [13] and the young 
women are usually incomplete in their own growth and often deficient in micronutrients [14,15]. 
Pregnancies at this time will make reproductive outcomes more likely to be negative as well as impacting 
on the health, nutrition and well-being of the adolescent. Studies of micronutrient status in adolescents, 
including when pregnant, have found poor micronutrient intakes and status [14], including in the  
UK [16], and increased risk of small-for-gestational-age (SGA) and low birthweight [LBW] infants at 
birth [10]. Adolescent pregnancy, besides negatively affecting the young mother’s own growth and 
nutritional status [17], is associated with a 50% increased risk of stillbirths and neonatal deaths, and 
increased risk of preterm birth, low birthweight, and asphyxia [18]. A review assessing the association 
between inter-pregnancy intervals with maternal, newborn, and child health outcomes found that short 
inter-pregnancy intervals (<6 months) were also associated with a higher probability of maternal anaemia 
(32%) and stillbirths (40%) whereas longer intervals (>60 months) were associated with an increased risk 
of pre-eclampsia [19]. 
3. Micronutrients during Pregnancy 
Information concerning vitamin and mineral metabolism and requirements during pregnancy are 
surprisingly imprecise, largely because of the complexity of maternal metabolism during pregnancy [4,20] 
and interactions between micronutrients. Overall nutrient requirements are increased during pregnancy 
due to the greater needs of the mother’s own increase in body tissue reserves and metabolic demands, 
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and the development of placenta and the foetus [21,22]. Requirements for many, but not all, 
micronutrients also increase during pregnancy [21]. However the increased requirements will depend on 
existing nutritional status, rate of weight gain and availability of adequate nutrition and co-existing 
disease. For micronutrients especially, adequacy can be difficult to assess due to plasma volume 
increases and often-poor biomarkers [23,24]. Nutrient-binding proteins that transport micronutrients also 
demonstrate decreased concentrations [21]. 
Iron and iron deficiency anaemia: iron deficiency anaemia (IDA) leading to a decrease in oxygen 
carrying capacity is one of the most common pregnancy-related complications [23,25]. The majority of 
the 1.62 billion people currently affected by anaemia are women or young children [25]. The global 
prevalence in pregnant women has fallen only slightly since 1995 from 43% to 38% [25]. The global 
prevalence of severe anaemia on the other hand, which poses the greatest risk for maternal mortality, 
has shown a greater relative reduction but still only from 2.0% to 0.9%, and overall the risk is far higher 
in women of LMIC [25]. About half of all anaemia is estimated to be attributable to iron deficiency, 
depending on the geographic and disease environment. Much of the other (approximately) half is caused 
by diseases such as malaria, HIV and parasites, and by deficiencies of other micronutrients such as 
vitamin A, folate and zinc [22], again according to the local environments. 
The apparent increased risk of anaemia during pregnancy is confounded by the plasma volume 
expansion at about six weeks into pregnancy [23], although red blood cell mass does not increase 
proportionately to the expanding plasma volume. Plasma volume increases by about 48% while red cell 
mass only increases by about 18% [23]. Iron deficiency itself, even before manifest as anaemia, affects 
both mother and child [23] and in the mother includes cognitive impairment, decreased physical activity 
and reduced immunity, and possibly more subtle impairments. Where there is real iron deficiency, this 
decreases the mother’s ability to synthesize hemoglobin and transport oxygen [26]. The foetus 
developing in-utero has no direct contact with the atmosphere and depends on the mother for oxygen, 
although foetal hemoglobin does also have a higher affinity for oxygen which helps to ensure that the 
developing foetus’ oxygen requirements can be met [27]. 
Young children who are the offspring of anaemic mothers, or are anaemic themselves, usually have 
poor development. A recent overview reported on a relatively recent meta-analysis that established the 
strong causal link between maternal iron deficiency and adverse outcomes [28]. Amongst other things, 
iron deficiency is thought to affect the optimal development of the foetal brain [20] and in mice at least, 
gestational iron deficiency of the mother differentially alters the structure and function of white and grey 
matter brain regions of the offspring [29]. A recent study found that psychosocial stimulation benefitted 
development in non-anaemic children but not in anaemic, iron-deficient children [30]. This would 
suggest in addition to iron treatment, children with IDA may require more intense or longer interventions 
than for young children neither anaemic nor iron deficient. There have been studies now with many years 
of follow-up that have demonstrated direct positive association between maternal Hb levels during 
pregnancy and educational achievements of off-spring later in life. One, from Finland, has demonstrated 
improvements 31 years later [31]. The study authors suggest that that iron prophylaxis even at fairly late 
stages of pregnancy may be beneficial for the offspring [31]. However, while iron deficiency is to be 
avoided in pregnancy, iron supplements and increased iron stores in the third trimester have been linked 
to maternal complications such as gestational diabetes and increased oxidative stress and risk of 
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preeclampsia [32]. The author notes that anaemia and iron deficiency anaemia are not synonymous, 
including among low income and minority women in their reproductive years [32]. 
Iodine: Unlike most essential dietary nutrients, iodine status is not linked so much to socio-economic 
development but more to geography [33]. Its critical significance during pregnancy is, rather than on 
maternal health directly, due to the devastating impact on the foetus of deficiency, including cretinism 
and impaired growth. Nevertheless, reproductive outcomes are affected with increased risk of stillbirths, 
abortions, and congenital abnormalities. Maternal urinary iodine has also been positively associated with 
birth weight, length and head circumference in male offspring in a recent study of a Bangladeshi 
population of pregnant women [2], as well as the well-recognized impact on offspring cognitive 
impairment as described below. 
Calcium: Calcium supplementation is associated with a reduction in pre-eclampsia as well as LBW 
and pre-term birth [18]. Gestational hypertensive disorders are the second main causes of maternal 
morbidity and mortality, as well as being associated with an increased risk of pre-term birth and foetal 
growth restriction [34]. As calcium supplementation during pregnancy reduces the incidence of 
gestational hypertension by 35%, pre-eclampsia by 52%–55% and pre-term births by 24% [35],  
the World Health Organization (WHO) now recommends 1.5 g to 2.0 g of elemental calcium per day for 
pregnant women with low dietary calcium intakes. 
Other minerals: Other trace element deficiencies that have been described as possibly associated with 
complications in pregnancy, childbirth or foetal development include copper, magnesium, selenium and 
zinc [22]. While a Cochrane review found that zinc supplementation in pregnancy may result in a 14% 
reduction in preterm birth [36], this decrease was not accompanied by a similar reduction in stillbirths, 
neonatal death, SGA, or low birthweight. The Lancet Series on Maternal and Young Child 
Undernutrition concluded there is insufficient evidence at this point for policy to be made on zinc 
supplementation during pregnancy [18]. 
Folate: folate deficiency leading to megaloblastic anemia is the second most common cause of 
anaemia during pregnancy [23]. Folate, a B-vitamin, has an important role in the synthesis and 
maintenance of DNA and therefore has an increased requirement throughout pregnancy supporting 
optimal growth and development of the foetus, as well as due to blood volume expansion and tissue 
growth of the mother [37]. Folate deficiency during pregnancy, especially around the time of conception, 
is strongly correlated with increased risk of neural tube defects such as spina bifida [38]. A recent study 
showed significant reductions in rates of both pre-eclampsia in mothers and SGA (small for gestational 
age) newborns with maternal folic acid supplementation (but no other associations between pregnancy 
and birth outcomes) [39]. 
Vitamin D: Vitamin D deficiency is estimated to affect one billion people globally and is increasingly 
recognized as being common amongst pregnant women [20]. Despite its important role in bone 
homeostasis, brain development and modulation of the immune system, the impact of antenatal  
vitamin D is still poorly understood [40], not least because of uncertainties with appropriate biomarkers 
and cut-off points. A systematic review suggested that women with circulating 25-hydroxyvitamin D 
(25(OH)D) concentrations <50 nmol/L in pregnancy have an increased risk of preeclampsia, gestational 
diabetes mellitus, preterm birth and SGA newborns [41]. A Cochrane review found a significant 
relationship between an increase in serum vitamin D concentrations at term and borderline reduction in 
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low birthweight [42] but there is yet not enough evidence for policy as the number of high-quality trials 
is thought to be currently too small to draw conclusions on its usefulness and safety [18]. 
Other vitamins: Deficiencies of yet other vitamins such as vitamin B12 and perhaps vitamin A may 
be important but evidence is sparse or conflicting [22,43]. There was an earlier recommendation by the 
FAO (Food and Agricultural Organization)/WHO of a 40% increase in the vitamin B-12 dietary 
allowance to meet foetal demands and increased metabolic needs [21]. As pregnancy does not require 
additional vitamin E and it is common in most diets, additional vitamin E is unlikely to be required [21]. 
Observational or experimental data linking water-soluble vitamins to any risk of maternal mortality are 
apparently unavailable [21]; these vitamins, such as vitamin C, thiamin, niacin and riboflavin and others, 
do however appear to decline in serum or plasma levels, likely due to extra uptake by the foetus or 
haemodilution, or in the case of niacin also increased urinary excretion [21]. Most return to normal 
within a week of delivery [21]. Possible side-effects of overdosage of vitamin E and vitamin C in 
pregnancy are discussed below (Section 7.2). 
4. Interactions among Micronutrients 
Interactions between micronutrient-dependent physiological and biological actions can be both 
positive, e.g., zinc and vitamin A, and negative, as e.g., with zinc or copper and iron [43]. Addition of 
zinc to iron and folic acid supplements have been shown to attenuate or even negate the positive 
association with outcomes due to iron, probably related to the inhibitory role of zinc in iron  
absorption [44]. Maintaining a balance between antioxidants such as selenium, and pro-oxidants (such 
as iron can be) has also been described as desirable, beyond the need to meet recommended intakes [20]. 
Because pregnant women in resource-poor areas are at risk of multiple micronutrient deficiencies [43], 
both the effects of single micronutrient deficiencies, and multiple ones, as well as interactions among 
them, all need to be considered. As described above, micronutrient deficiencies during pregnancy are 
associated with adverse pregnancy outcomes, especially in women of lower socioeconomic status who 
tend to have more than one deficiency, and those of young age who are at risk of being undernourished 
and underweight [11,18]. When important clinically, such micronutrient/micronutrient interactions 
complicate public health recommendations and interventions, as some will be synergistic and some will 
be antagonistic [20,22]. Framing specific recommendations can be further complicated by human 
variability in uptake and utilization of micronutrients, and genomics and epigenetic changes due to early 
deficiencies during gestation. One recent meta-analysis e.g., strongly suggested the MTHFD1 G1958A 
polymorphism appears to be associated with increased maternal risk for NTDs (neural tube defects) in 
Caucasian populations [45]. Neural tube defects present as a wide range of phenotypes and the aetiology 
is multifactorial “with a large number of unclear genetic components, environmental conditions, and 
their interactions playing critical roles” [45]. This seems likely possible also for other micronutrients 
important in pregnancy outcomes. Multi-micronutrient supplementation is discussed below. 
5. Offspring of Micronutrient-Deficient Mothers 
Although pregnancy is the focus of this review, the effects of micronutrient deficiencies on their 
offspring also need to be addressed as part of the mother-child dyad. Perhaps the most noteworthy natural 
experiment demonstrating this necessity came about as a result of the Dutch famine of 1944 which 
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provided a unique opportunity to study the long term consequences of maternal nutritional status and 
health outcomes in offspring [46,47]. Before the famine ended in 1945, rations were as low as 500 Kcal 
per person [47]. Expectant mothers who were subjected to the famine became severely macro- and 
micronutrient deficient. The famine was directly observed to affect fertility, infant birth weight, maternal 
weight gain, and the development of the neonate’s central nervous system [47]. 
Assessing the impact of antenatal micronutrient status of pregnant women (especially when improved 
by supplementation) on the outcomes for their offspring is a challenge due to the need to follow the 
women through pregnancy and then the offspring, often in less than ideal settings for such research.  
In an important study from Nepal, intellectual functioning, including working memory, inhibitory 
control, and fine motor functioning among offspring at 7 to 9 years of age were positively associated 
with prenatal iron/folic acid supplementation in an area of high iron deficiency [8]. Related and similar 
findings of positive impact on the child of maternal antenatal supplementation have been found in 
Bangladesh [48], China [49] and in HIV-infected mothers in Tanzania [50]. A study from rural Viet 
Nam found that low maternal 25-hydroxyvitamin D levels in late pregnancy were associated with 
reduced language developmental outcomes at six months of age [40]. Maternal antenatal zinc 
supplementation may have beneficial long-term consequences for neural development associated with 
autonomic regulation of cardiovascular function in children at 54 months whose zinc-deficient pregnant 
mothers had received supplementation [51]. Even in areas of mild-to-moderate iodine deficiency, subtle 
reductions in the intelligent quotient of children in those areas may be reduced on average by 8–13.5 IQ 
points but can be corrected in populations by salt iodization [33]. On the other hand, there is increasing 
evidence of a positive impact of multiple micronutrient supplementation to deficient mothers on the 
growth and development of their offspring, although mechanisms are still unclear and findings 
inconsistent. This is probably because of different formulations and dosages of the supplements, rather 
than lack of effect. 
6. Gestational Micronutrient Deficiencies and Later Risk of Chronic Disease 
It has been noted that whereas micronutrient deficiencies are known to be associated with various 
shorter-term adverse outcomes of pregnancy, their effects on long-term health and later chronic disease 
of the children of such pregnancies are largely unknown. It is now generally accepted that early life 
nutritional exposures, combined with changes in lifestyle in adult life, can result in an increased risk of 
chronic diseases [52,53]. The excellent review by Christian and Stewart [52] that considered various 
strands of evidence, including animal studies, concludes that there are also strong suggestive links 
between intrauterine micronutrient status and the potential risk of chronic diseases but the underlying 
mechanisms are largely unclear. However, it is known that micronutrient status in foetal and early life 
can alter metabolism, vasculature, and organ growth and function, and so is likely to have consequences 
for increased risk of cardiometabolic disorders, adiposity, altered kidney function, and ultimately type 2 
diabetes and cardiovascular diseases [52]. Epigenetic influences, as mentioned previously, heritable 
long-term changes in gene expression which are not caused by changes in gene sequence [54], may also 
play a significant role in long-term pregnancy outcomes. Christian and Stewart [52] have suggested a 
conceptual framework for how maternal diet and micronutrient status may effect the development of 
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chronic disease; the most likely, given present knowledge, seem to be vitamin A, folate, iron and zinc 
and perhaps calcium and magnesium as shown in their conceptual framework (Figure 1). 
 
Figure 1. Conceptual framework by Christian and Stewart [52] for how maternal diet  
and micronutrient status may affect the development of chronic disease in the offspring. Gray 
boxes represent hypothesized pathways through which various micronutrient deficiencies may 
influence the growth, development, or function of the indicated systems. 
Numerous studies have found significantly higher morbidity and mortality rates amongst individuals 
who were exposed to the nutritional shortages during gestational developmental periods, compared to 
unexposed individuals as e.g., in the above-mentioned Dutch famine [46,55,56]. Exposure during early 
gestation was associated with increased glucose intolerance, increased prevalence of coronary heart 
disease, elevated atherogenic lipid profile, increased risk of obesity, increased risk of schizophrenia, and 
disturbances in blood coagulation [47,55,56]. Some of these morbidities were found to transcend 
generations, with higher rates of obesity and associated co-morbidities observed in second-generation 
offspring of males who were exposed to the famine prenatally [57,58]. It is known that nutritional 
deficiencies during pregnancy may result in epigenetic modifications to the human genome, resulting in 
changes to gene expression, without alterations to gene sequence. In the review by Christian and  
Stewart [52], of how deficient maternal micronutrient status might influence the development of chronic 
disease in the children, they suggest that micronutrient status might influence regulatory pathways, such 
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as hormonal adaptations and epigenetic gene regulation that can influence restricted growth and 
development in the developing foetus (Figure 1). In population-based prospective cohort studies, 
maternal hyper-homocysteinaemia (a biomarker of folate deficiency) was, for example, also linked to a 
higher risk of adiposity and type 2 diabetes in mothers and their offspring, both of which have future 
negative outcomes, and in the shorter term, lead to negative birth outcomes [39]. 
An emerging trend, in terms of noncommunicable diseases, is that of increasing numbers of overweight 
and obese mothers such as is now happening in LMIC, often at the same time, as their underweight 
children—the so-called “double burden of malnutrition”. This is important because of increasing 
evidence e.g., from the Danish National Birth Cohort studies, that obese women have a higher risk of 
micronutrient deficiencies [59], and so micronutrient deficiencies associated with pregnancy in 
overweight/obese women are becoming increasingly an issue in both affluent and lower- and  
middle-income countries. High-dose supplementation with vitamin C and vitamin E has been found to 
not prevent preeclampsia but to increase the rate of babies born with low birthweight [59]. A later 
systematic review confirmed the lack of effect on preeclampsia and also found an increased risk of 
developing gestational hypertension and premature rupture of membranes, with a decreased risk of 
abruptio placentae [60,61]. There does not appear to be evidence to recommend supplementation with 
vitamins C and E. 
7. Addressing the Problem 
Short-term clinical interventions for micronutrient deficiencies may be critical for the immediate 
pregnancy and should obviously be addressed on presentation. Particularly in countries with  
under-resourced Health Systems, concurrent antenatal preventive measures also need to be in place and 
must be strengthened and scaled-up for optimizing maternal, neonatal and young child outcomes. The 
extended roles of other opportunities throughout the life course such as the adolescent young woman 
[28] are being increasingly recognized as further opportunities. The distinction will be made here 
between clinical interventions, those occurring during the pregnancy and delivery such as antenatal 
supplementation e.g., with iron and folic acid and obstetric care, and those occurring before the 
pregnancy and periconceptionally, such as preventive weekly iron and folic acid supplementation [62] 
which are seen as more public health and nutrition interventions. 
7.1. Clinical 
There have been significant strides in addressing perinatal nutritional issues, especially at the public 
health level. Consequently, the risk of nutritional insufficiency in pregnant women in most middle and 
high-income populations has been drastically reduced but remains a real risk in many LMIC women. 
Clinical care is used here in the sense of care before pregnancy, during the actual pregnancy, and during 
delivery and the neonatal phase. For convenience, “antenatal” refers to the pregnant women’s care, 
whereas “perinatal” is larger including the periconceptional time and even before, as well as including 
immediately after birth. In terms of micronutrients, these clinical interventions include oral tablet 
supplementation, improved diets and nutrition education, food supplementation, monitoring of anaemia 
levels where facilities permit, management of weight gain, and encouragement to plan for breastfeeding, 
and related activities such as delayed cord clamping to improve neonatal iron stores. 
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7.1.1. Supplementation with Micronutrient Tablets 
The Recommended Dietary Allowance RDA of iron increases by about 50% during pregnancy (from 
18 mg to 27 mg). Due to the fact that the median dietary intake of iron in pregnant women is considerably 
lower than the Estimated Dietary Requirement (EAR) for iron, even in an affluent country like the USA, 
and often lower still in LMIC, it is recommended that pregnant women take iron supplements [63,64]. 
Antenatal iron and folic acid supplementation is a well-established intervention but the coverage and impact 
has been poor despite clear WHO recommendations for both anaemic and non-anaemic pregnant women 
and by national bodies [63–65]. Some other countries, especially more affluent ones, often have their 
own policies [64,65] including not recommending iron and folic acid at all in non-anaemic pregnant 
women. However, many women in such countries are anyway receiving a multiple micronutrient 
supplement [65], and there is a good body of research suggesting this should be recommended for 
pregnant women in LMICs [10,18,66] and there is growing support for the potential replacement of iron-
folic acid supplements in pregnancy with multiple micronutrient supplements in populations at risk [18]. 
All bodies, multilateral or national, recommend supplementation to be complemented by healthy 
antenatal diets. 
The reasons for the generally poor coverage of the existing recommended iron/folic acid tablets have 
been extensively reviewed [3]. They include: poor antenatal attendance especially in the first  
two trimesters; the effects of lower status of women; the taste and side effects of iron-containing tablets 
(especially lower quality ones); logistical issues; lack of conviction of positive impact by health workers; 
fear of larger babies where there is inadequate obstetric care; and so on [3]. Nevertheless, where coverage 
is good, the results are impressive and can be expected to have an impact on the mother’s health, reducing 
anaemia and improving birth outcomes, and a likely impact on infant and young child outcomes, as noted 
above. A study in rural western China found that antenatal supplementation with iron-folic acid was 
associated with longer gestation and a reduction in early neonatal mortality compared with only folic 
acid, whereas multiple micronutrient supplements were associated with a modest increased birth weight 
compared with folic acid [67]. Despite the weight gain, there was no significant reduction in early 
neonatal mortality [67]. In 2012, the World Health Assembly endorsed nutrition targets for 2025 that 
included a 50% reduction in the number of women of reproductive age affected by anaemia compared 
with 2011 [25]. 
There is accumulating evidence that folic acid by supplementation has an additional protective effect 
against adverse pregnancy outcomes, as well as the now well-established reduction in neural tube defects 
(NTD) [18]. Studies have suggested improved neurodevelopmental outcomes in children of mothers 
with higher blood folate concentrations or mothers receiving antenatal folic acid supplements [37]. The 
RDA increases by 50% during pregnancy, from 400 μg/day to 600 μg/day [20]. This is hard to 
accomplish without consumption of folic acid-fortified foods or folic acid supplements. For this reason, 
periconceptional supplementation of 400 μg/day of folic acid is recommended internationally for women 
of childbearing age in order to minimize neural tube defects [20]. Except in some settings, coverage has 
not usually been impressive, especially to those of poor socio-economic status and adolescents who are 
amongst those most at risk of unplanned pregnancies. For example, the CDC reports that about 50% of 
U.S. pregnancies are unintended and most women are not aware that they are pregnant until they are 
about two months into the pregnancy. However, the neural tube closes between 23–27 days after 
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conception [20], and so this is already too late. An alternative approach that has been considered is to 
recommend folic acid supplements for all women who are of child-bearing age. However, long term 
folic acid supplementation on the off chance that an unplanned conception occurs has significant 
implementation and cost implications. Where pregnancies are generally carefully planned, as was the 
case in one experience in China, folic acid supplementation has been successful. However, the public 
health food-based population approach of fortification is now the accepted intervention in most 
countries, and where instituted, has shown a dramatic reduction in the incidence of NTDs [38]. 
There are also several other clinical considerations to be made when supplementing with folic acid. 
For example, folate may mask symptoms of megaloblastic anemia, which could be an indicator of 
vitamin B-12 deficiency [68]. Indicators of low vitamin B-12 are associated with adverse pregnancy 
outcomes, anaemia, low birthweight, and intrauterine retardation [9]. By the possible masking of vitamin 
B-12 deficiency, folic acid could make it difficult to detect and remedy B-12 deficiency,  
but the evidence for this happening with fortification of cereal staples is mixed. Oral supplementation of 
urban Indian women with vitamin B-12 throughout pregnancy and early lactation significantly increased 
vitamin B-12 status of both mothers and infants [9] and so worth considering where vitamin B12 intakes 
are marginal. There are also concerns from observational data of possible increases in rates of some 
cancers with higher levels of folic acid in the diet due to the relatively high levels used in  
fortification [20]. 
As noted, WHO now recommends calcium supplementation to reduce the risk of hypertensive 
diseases in pregnancy. However calcium requires large and frequent tablets, as well as the 60 mg of iron 
and 400 µg of folic acid and where the iron and calcium may negatively react intra-intestinally [34]. 
Recently a novel micronutrient powder containing micro-encapsulated pH-sensitive calcium in addition to 
iron and folic acid has been designed to facilitate early intestinal release of the iron and delayed calcium 
release [34]. 
In affluent countries, where supplementation with antenatal multimicronutrient supplements is 
relatively common and often recommended [65], use of targeted antenatal micronutrients probably has 
the potential to decrease infant morbidity and mortality in anaemic and deficient women, especially  
low-income urban women [69]. In a Canadian study, self-reported vitamin supplementation was 
associated with decreased odds of miscarriage although other associated positive health-related behaviours 
also likely contributed [70]. On the other hand, an earlier systematic review found that taking vitamin 
supplements prior to pregnancy or in early pregnancy, did not prevent miscarriage or stillbirth but the 
mothers appeared to be less likely to develop pre-eclampsia (but were more likely to have a multiple 
pregnancy) [71]. The evidence is not yet entirely clear, as iron and folic acid supplements in Indonesian 
women significantly reduced the risk of early neonatal death [72]. Similarly a double-blind  
cluster-randomized trial, also in Indonesia, found that maternal multiple micronutrient supplementation, 
as compared with iron/folic acid, reduced early infant mortality, especially in undernourished and 
anaemic women [73]. The size of the pregnant women appears to modify the effect and well-nourished 
women may be less appropriate for supplementation where there is inadequate clinical support. 
Supplementation with multiple micronutrient formulations has a certain logic to it given the  
multiple micronutrient deficiencies that frequently occur together and the interactions between  
micronutrient-dependent physiological and biological actions [43]. Current evidence has been described 
as suggesting that vitamins and minerals have added bio-functionality which may be particularly 
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important in pregnancy with synergisms e.g., between folic acid and vitamin B12, possibly enhancing 
their biological potential—in this case to further reduce the occurrence of NTDs [20]. 
An independent systematic review and meta-analysis of 12 randomized, controlled trials comparing 
multiple micronutrient supplementation with iron-folic acid supplementation found that both supplements 
were equally effective in reducing anaemia (even though iron content was often lower in the 
multimicronutrient supplement) and resulted in a small, significant increase in mean birthweight; larger 
micronutrient doses appeared to have a greater impact [10]. The findings of other intervention trials, 
especially effectiveness trials, have been variable, although efficacy is largely accepted. Many factors 
affect the impact, such as baseline iron and/or anaemia levels, diet, the disease environment and 
importantly it seems the size of the pregnant woman. A recent study in Chinese women e.g., showed that 
compared with controls taking folic acid, prenatal iron/folic acid or multiple micronutrient supplements 
improved iron status later in pregnancy but did not affect perinatal anaemia in women with no or mild 
anaemia [74]. 
Nevertheless, “despite encouraging high compliance to community-based supplementation, a proportion 
of mothers remain anaemic, suggesting a need to also address parasitic and other infections and malaria” 
[10,13]. It is also worth noting that meaningful improvements with antenatal multiple micronutrients in 
height and cognitive development in children by two years of age have been observed, although these 
findings have been less consistent. Nevertheless, following these findings, it was concluded that 
replacing iron-folic acid supplements with multiple micronutrients in the package of health care, 
including improved obstetric care of health and nutrition interventions, would improve the impact of 
supplementation on birthweight, small-for-gestational age neonates, and perhaps child growth and 
development [10]. Despite some initial concern in some settings of (non-significant) risk of increased 
neonatal mortality [75] (not found in other reviews e.g., Haider et al. [66]), the conclusion immediately 
above was later endorsed by the Lancet Series (2013) following further evidence supporting the  
approach [18]. Trials are underway in a number of countries at present. Supplementation with 
multivitamins (vitamin B complex, vitamin C and vitamin E) also significantly decreases the risk of 
adverse pregnancy outcomes among HIV-infected women [76]. 
A consensus appears to be emerging on the usefulness of antenatal supplementation with 
multimicronutrients, especially for improvements in birthweights [10,18], at least in LMIC. 
Replacement of iron-folic acid with multiple micronutrient supplements in pregnancy, as a public health 
recommendation in at-risk populations, seems warranted, although further evidence from effectiveness 
assessments might be needed to guide a universal policy change [18]. However, delivery platforms for 
micronutrient antenatal care are a constraint in many settings e.g., a recent study in PNG showed how 
socio-cultural, health care staff attitudes and economic factors all affect antenatal care attendance and 
that only a third of women receive any antenatal care during pregnancy [77]. Clearly, however effective 
micronutrient interventions are for pregnant women, other factors, including logistics need to be addressed 
in many settings. 
7.1.2. Food Supplementation 
Food supplementation, especially in emergency and resource-poor settings is increasingly  
evidence-based. Emergency rations and supplies in particular have invested considerable resources in 
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ensuring that the micronutrient content of such supplements are adequate while recognizing that in 
undernourished pregnant mothers it is the low energy (caloric) content of the available diets that is the 
main risk. The MINIMat randomized trial in Bangladesh tested the hypothesis that antenatal multiple 
micronutrient supplementation and an early invitation to food supplementation would improve birth 
outcomes [78]. They found that among these pregnant women from poor communities, supplementation 
with multiple micronutrients, as well as just iron and folic acid, combined with food supplementation, 
resulted in decreased childhood mortality. A recent review concluded that a dietary pattern containing 
several protein-rich food sources, fruit, and some whole grains is associated with a reduced risk of 
preterm delivery [1]. A platform used with limited experience (in pregnant women) has been the use of 
multimicronutrient powders (added to food) during the antenatal period, or more recently lipid-based 
supplements that supply both dietary energy, protein and micronutrients [79]. Studies show that use of 
micronutrient fortified supplementary foods, especially those containing milk and/or essential fatty acids 
during pregnancy, increase mean birthweight by around 60–73 g [80]. Fortified food supplements 
containing milk and essential fatty acids, along with micronutrients, offer benefits for improving maternal 
status and pregnancy outcome [80]. Fortified beverages containing only multiple micronutrients have 
been shown to reduce micronutrient deficiencies such as anaemia and iron deficiency. Food 
supplementation, while clearly effective in undernourished mothers will not be discussed further here, 
as it is mainly an intervention to increase dietary energy and the micronutrients needed to accompany it 
are largely known. Other antenatal clinical advice and monitoring, while clearly essential to the mother’s 
health and reproductive outcomes, are also not discussed here but recognized as part of the larger care 
of the mother, of which adequate micronutrient status is but one part. 
7.2. Public Health Measures 
Public health and nutrition measures aim to improve pregnancy outcomes in general, especially for 
those women with limited access to good antenatal clinical care, and to reduce the risk of periconceptional 
micronutrient deficiencies, among other ancillary benefits. The most commonly used approaches,  
in terms of micronutrients includes: blanket supplementation, and sometimes targeted supplementation, 
policies and programmes; fortification; and, general measures to improve diets and micronutrient intakes 
and general health. 
7.2.1. Supplementation 
Public health supplementation includes blanket approaches e.g., all women of reproductive age, 
especially adolescents, receiving weekly iron and folic acid supplements [62]. The use of weekly iron 
and folic acid supplements through schools or factories has proven efficacy and is recommended by the 
WHO [62]. As a preventive measure it has not been taken up by governments and requires more 
implementation experience in national programmes, despite already promising experiences in some 
countries such as the Philippines and Vietnam. Targeted, preconceptional supplementation such as folic 
acid supplements for young women intending to get pregnant has had limited use and success, not least 
because the majority of pregnancies are not planned, as discussed above. Targeted iron/folic acid 
supplementation to pregnant women has a long history and continues to be recommended nationally and 
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by the WHO but has been relatively unsuccessful due to poor covergae, especially in LMIC, as also 
discussed above. 
Oral iodized oil has also been used for this purpose but as a public health measure has been supplanted 
by iodized salt programmes. Where coverage by iodized salt is sub-optimal, WHO recommends that 
pregnant (and lactating) women should be given an oral supplement of iodized oil [81]. Although  
38 million newborns are born iodine-deficient in LMIC, affluent countries are also increasingly at risk 
unless supplementary measures e.g., iodine fortification of bread or supplementation of pregnant women 
are undertaken. Even in affluent countries such as the UK and Australia, poor iodine intake in pregnancy 
predicts lower child IQ [82] and in a small recent study in South Eastern Australia, less than half (46%) 
of pregnant women were following national recommendations and only 18.5% believed they needed a 
supplement and only a third (34.5%) had been given adequate advice by their medical practitioner [83]. 
In the USA, iodine supplements are used by only 22% of pregnant women [82]. Such findings explain 
the continued global emphasis on salt fortification with iodine [84], despite the challenges of other 
recommendations for populations to reduce their salt intake to reduce the prevalence of hypertension. 
7.2.2. Nutrition Education, Dietary Improvement and Improved Public Health Measures 
Other interventions that impact on the micronutrient status during pregnancy include dietary measures 
and other public health and social interventions such as deworming, education and horticultural activities. 
While the risk of being born low birthweight is significantly greater with moderate preconception 
anaemia [85], it has also been noted that in many unsafe settings, mothers purposefully “eat-down” 
aiming to have a smaller neonate. A failure of nutrition education has also been implicated in poor diets 
as well as some dietary taboos [21] and soil-transmitted helminthes [86]. Nevertheless, where access and 
availability to foods is possible, improving diets by including such items as eggs and animal-source 
foods are likely to provide protein, energy and micronutrients. However, such foods are not often 
available to the very poor, or there are cultural constraints, which is why food supplements to such 
pregnant women is now a recommendation [3,18]. 
International guidelines recommend routine safe and protective prevention and treatments, during 
pregnancy, to reduce hookworm, malaria and other infections such as schistosomiasis [87]. Despite the 
effectiveness of such programmes, and because women with high levels of hookworm or malaria 
infections are at high risk of anaemia [86], there continues to be a need for more general scaling-up of 
coverage in affected populations. A recent randomized trial (that included pregnant women with anaemia 
and iron deficiency at baseline) in a malaria endemic area found major gains in birthweight, without 
apparent effect on Plasmodium infection and urged that universal coverage of iron supplementation (60 
mg per day) should be scaled-up, preferably with cover by IPT (intermittent preventive treatment of 
malaria) [88]. A systematic review and meta-analysis recently concluded that more evidence is needed 
to the long-standing, and often contentious, role of giving iron in malaria-endemic populations and so 
concluded that currently it is prudent to provide iron in combination with malaria prevention during 
pregnancy [89]. There is increasing consensus in this view, along with the need for concomitant 
improved obstetric care and diet. 
Attention to adolescent girls as an important preventive strategy is increasingly recognized,  
despite some strong cultural and social constraints. It has been observed that, even in affluent settings, 
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adolescents are more likely than adults to consume energy-dense, micronutrient-poor diets and to have 
adverse pregnancy outcome such as increased risk of SGA [16]. The risk is likely to be even greater in 
food-insecure populations such as in Central Africa [90]. Other non-direct micronutrient interventions 
that could be expected to have a positive impact on nutrition and health of pregnant women (at least 
where most births are within a marital relationship), include interventions to increase the age at marriage 
and first pregnancy are important, and can reduce repeat adolescent pregnancies by 37% [18]. The 
African Union has recently launched a new campaign to end child marriage in Africa [91] which, if 
successful would be expected to have positive reproductive outcomes. 
Table 1, derived from Bhutta et al. [18], shows micronutrient interventions that have an adequate 
evidence base to be recommended for women of reproductive age and during pregnancy (as well as 
maternal supplementation with balanced energy and protein including through supplementation). 
7.2.3. Fortification 
Fortification can be considered a dietary intervention and one that has recently been recommended 
by the Lancet Maternal and Young Child Undernutrition series and has been in practice for over sixty 
years in many affluent countries [18]. Bhutta et al. [18] concluded that “fortification has the greatest 
potential to improve the nutritional status of a population when implemented within a comprehensive 
nutrition strategy, including for pregnant women and has the advantage of reaching women before 
pregnancy”. Iodized salt programs are now implemented in many countries worldwide, and the past two 
decades have shown considerable progress, so that globally, 76% of households are now adequately 
consuming iodized salt. On the other hand, nearly 30% of school-aged children are estimated to have 
insufficient iodine intakes and global progress appears to be slowing [84]. The need for continual global 
scaling-up and consolidation of existing programmes has already been commented upon. There  
have also been efficacy, and limited effectiveness studies of doubly fortified salt with iodine and 
encapsulated iron. 
The provision of balanced energy protein supplementary foods to underweight pregnant women  
was also considered to have enough evidence of reduction in SGA and stillbirths and improved 
birthweights for widespread implementation, whereas maternal vitamin D and zinc supplementation, 
while promising, were considered to have insufficient evidence [18]. 
Fortification of cereal flours with iron and often other micronutrients such as some B group vitamins, 
and more recently zinc and even selenium, has been in existence e.g., in the USA, for over 60 years, and 
now 80 countries globally have legislation to mandate fortification of at least one industrially milled 
cereal grain (79 countries have legislation to fortify wheat flour; 12 countries to fortify maize products; 
and five countries to fortify rice) [38]. Costa Rica is the only country that mandates fortification of all 
three grains, and Papua New Guinea is the only country that requires only rice fortification. Currently 
the 79 countries that mandate required fortification of wheat flour produced in industrial mills require at 
least iron and folic acid, except Australia, which does not include iron, and Congo, the Philippines, 
Venezuela, and the United Kingdom, which do not include folic acid. Additionally, seven countries 
fortify at least half their industrially milled wheat flour through voluntary efforts and it has been 
estimated that about a third (31%) of the world’s industrially milled wheat flour is now fortified with at 
least iron or folic acid through these mandatory and voluntary efforts [38]. Other success stories include 
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the fortification of sugar with vitamin A in Central America. A continuing challenge is that populations 
most at risk of deficiency either cannot afford fortified foods or, especially in lower-income countries, 
they are not available to them. Nevertheless, fortification is likely to be an increasingly major part of the 
reduction of micronutrient deficiencies, including during pregnancy. 
Table 1. Nutrition/micronutrient interventions for women of reproductive age and during 
pregnancy (based on Bhutta et al. in the Lancet series of 2013 which has estimates of size of 
the significant effects and the evidence from which they come [18]). 
Intervention Setting 
Comments (Only Significant 
Findings and Original Systematic 
Review References) 
Folic acid supplementation 
WRA * LMIC ** and affluent countries [92] 
Pregnant women Mostly more developled countries [93] 
Iron and iron-folic acid supplementation 
WRA 
Both LMIC and affluent countries. 
Interventions mainly given in school settings to 
adolescents and evidence mostly from 
effectiveness studies 
Intermittent iron supplementation 
(once or twice a week)—reduces 
anaemia rates [94] 
Pregnant women Both LMIC and affluent countries. Intervention 
Reduction in LBW ***, reduction 
in anaemia rates at term and  
improved Hb [95] 
Multiple micronutrients (MMN) supplementation 
Pregnant women 
LMIC and affluent countries. Studies compared 
MMN with two or fewer micronutrients 
Reduction in LBW and currently 
insignificant data for 
neurodevelopmental outcomes  
in offspring [96] 
Calcium supplementation 
Pregnant women 
LMIC and affluent countries.  
Mostly effectiveness trials 
Reduction in pre-eclampsia as well 
as LBW and pre-term birth [97] 
Iodine through salt iodization programmes 
Pregnant women Mostly LMIC. Mostly effectiveness trials. 
Cretinism at 4y reduced, improved 
birthweight, developmental scores 
higher in young children [98] 
* WRA = women of reproductive age; ** LMIC = Low- and Middle-Income Countries; *** LBW = Low  
birth weight. 
8. Conclusions 
The deficiencies in micronutrients that affect many women of reproductive age are now known to be 
associated with adverse maternal and perinatal outcomes. These adverse outcomes can have longer-term 
impacts into adulthood [18,99,100]. Personal, social and economic costs are high [3]. Maternal 
undernutrition has been described as one of the most neglected aspects of nutrition in public health 
globally [99,100]. Consequently, low-cost public health interventions that might help to ameliorate the 
impact of poor nutrition and diets, high disease burdens and the socio-cultural factors contributing to the 
 
Nutrients 2015, 7 1760 
 
high levels of these micronutrient deficiency problems during pregnancy, and before, continue to need 
scaling-up in scope and coverage [101]. 
Important factors besides inadequate diet and diseases that are indirectly related to maternal, foetal, 
and neonatal nutritional status and pregnancy outcomes include young age at first pregnancy and 
repeated pregnancies. Young girls who are not physically mature enter pregnancy with depleted nutrition 
reserves and often anaemia [102] and other micronutrient deficiencies [3,43]. While micronutrient 
deficiencies can undoubtedly have profound influences on the health of the mother and her child,  
there remain considerable areas of uncertainty and controversy that has made the development of robust 
public health recommendations a challenge [20]. Along with the noted challenges to get compliance, 
especially periconceptionally and in settings with limited health care capacity, and questions of how 
optimal micronutrient formulations and dosages are established, Berti et al. [20] have called for 
“adequately powered, randomized controlled trials with long periods of follow-up” to “establish 
causality and the best formulation, dose, duration and period of supplementation during pregnancy”. 
However, the methodological issues in doing this would be considerable, especially in establishing 
causality. Consequently, factors that are known to be important, such as entering a pregnancy adequately 
nourished, being aged beyond adolescence, and good health and obstetric care, and nutrition education 
and support, should be scaled-up actively in the meantime. 
If proven to be effective and safe in national health care systems, supplementation with 
multimicronutrients, at least in pregnancy, could complement preventive supplementation with weekly 
iron and folic acid in vulnerable populations. This could help break the intergenerational reality of low 
birthweight infants growing up disadvantaged and stunted and so at high-risk of repeating the same 
cycle. Whereas there has been a lot, if insufficient, attention paid to iron deficiency anaemia in pregnant 
women, most of the other involved micronutrients, are less well characterized [20,43]. Micronutrients 
likely to be important for maternal, infant and child outcomes include iron, iodine, folate, vitamin B12, 
vitamin D, calcium, and selenium, probably zinc and maybe others, along with appropriate dietary 
energy intakes. In addition to programmes to reduce micronutrient deficiencies such as micronutrient 
supplementation and food fortification, needed complementary interventions should optimally improve 
overall maternal nutrition, address household food insecurity, reduce the burden of maternal infections 
such as HIV and malaria, improve sanitation, and actively address gender and social disadvantage. 
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